Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Genet Mol Res ; 15(3)2016 Aug 19.
Article in English | MEDLINE | ID: mdl-27706567

ABSTRACT

Cinnamon is the main component of Sanyangxuedai, which is one of the effective traditional Chinese medicines for treating malignancies. Leukemia is a prevalent malignant disease that Sanyangxuedai has been used to treat. Although successful in several studies, there is a lack of solid evidence as to why Sanyangxuedai has an effect on leukemia, and little is known about the underlying mechanisms. In this study, the active ingredients of cinnamon were isolated, purified, and identified. The transwell transport pool formed with the Caco-2 cell model was used to filter the active ingredients of cinnamon by simulating the gastrointestinal barrier in vitro. Moreover, the cell morphology, cell cycle status, apoptosis status, and antigenic variation of the cell surface antigens were observed and measured in K562 cells after treatment with the active ingredients of cinnamon. Our results showed that 50-75 µM was a safe concentration of cinnamon extract for treatment of K562 cells for 72 h. The cinnamon extract caused growth inhibition of K562 cells. Cinnamon extract seemed to arrest the cells at the G1 stage and increased the apoptosis rate significantly. Interestingly, cinnamon extract treatment upregulated the expression of erythroid and myeloid differentiation antigens and downregulated that of the megakaryocytic differentiation antigens in a dose-dependent manner. Our findings indicate that cinnamon extract from Sanyangxuedai may be effective for treating leukemia.


Subject(s)
Cinnamomum zeylanicum/chemistry , Leukemia/drug therapy , Plant Extracts/pharmacology , Stem Cells/drug effects , Apoptosis/drug effects , Caco-2 Cells , Cell Cycle/drug effects , Cell Differentiation/drug effects , Cell Proliferation/drug effects , Humans , K562 Cells , Leukemia/pathology , Stem Cells/metabolism , Stem Cells/pathology
2.
Clin Exp Immunol ; 175(2): 268-84, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24117055

ABSTRACT

An increase in interleukin (IL)-17A-producing cells, particularly at sites of tissue inflammation, is observed frequently, yet the mechanism is not fully understood. This study aims to dissect the role of IL-17 in autoimmunity-mediated neuroinflammation. The cytokine milieu containing elevated IL-17, which often appears in active states of autoimmunity, was mimicked in vitro by a supernatant obtained from rat peripheral blood monocytes stimulated with phorbol mystistate acetate (PMA)/ionomycin. The application of such inflammatory media on only primary cultured cerebellar granule neurones resulted in significant apoptosis, but the presence of astrocytes largely prevented the effect. The supernatants of the stimulated astrocytes, especially those that contained the highest level of IL-17, achieved the best protection, and this effect could be blocked by anti-IL-17 antibodies. Protein IL-17 inhibited intracellular calcium increase and protected the neurones under inflammatory attack from apoptosis. IL-17, but not interferon (IFN)-γ, in the inflammatory media contributed to astrocyte secretion of IL-17, which depended on the Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway activation. The astrocytes that were treated with IL-17 alone or with prolonged treatment of the inflammatory media failed to produce sufficient levels of IL-17. Moreover, confirmatory data were obtained in vivo in a monophasic experimental autoimmune uveitis (EAU) in Lewis rats; in this preparation, the high-level IL-17-containing the cytokine milieu was demonstrated, along with IL-17 secretion by the resident neural cells. The antagonism of IL-17 at a late stage disturbed the disease resolution and resulted in significant neural apoptosis. Our data show a dynamic role of IL-17 in the maintenance of homeostasis and neuroprotection in active neuroinflammation.


Subject(s)
Astrocytes/immunology , Inflammation/immunology , Interleukin-17/metabolism , Neurons/immunology , Animals , Antibodies, Blocking/immunology , Apoptosis/immunology , Astrocytes/metabolism , Autoimmunity/immunology , Interferon-gamma/metabolism , Interleukin-17/immunology , Janus Kinases/metabolism , Leukocytes, Mononuclear/drug effects , Neurons/metabolism , RNA, Messenger/biosynthesis , Rats , Rats, Inbred Lew , Rats, Wistar , STAT Transcription Factors/metabolism , Tetradecanoylphorbol Acetate , Uveitis/immunology
3.
J Nanosci Nanotechnol ; 9(2): 951-4, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19441429

ABSTRACT

Zn0.86Co0.14O powder and thin films were prepared by standard solid-state reaction processes and radio-frequency (RF) magnetron sputtering. Magnetic measurements indicate that the powder is paramagnetic for temperatures above 3 K, while the thin films annealed in vacuum are ferromagnetic at room temperature. The saturated magnetization was found to be about 0.6 microB/Co, while the coercive force was found to be 200 Oe at room temperature. The very similar results were also obtained in Zn0.96Mn0.04O powder and thin films. Such different results for the powder and thin films indicate that growth conditions and defects play an important role in producing ferromagnetism.

SELECTION OF CITATIONS
SEARCH DETAIL